Literature DB >> 25684982

Tumour inflammatory response: adding fuel to the fire?

M Valdes1, M R Chasen2.   

Abstract

Year:  2015        PMID： 25684982      PMCID： PMC4324346          DOI： 10.3747/co.22.2303

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  21 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Continuous cultures of fused cells secreting antibody of predefined specificity. 1975.

Authors:  G Köhler; C Milstein
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

3.  Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study.

Authors:  Michael J Proctor; Paul G Horgan; Dinesh Talwar; Colin D Fletcher; David S Morrison; Donald C McMillan
Journal:  Cancer       Date:  2013-04-10       Impact factor: 6.860

4.  Serum C-reactive protein predicts poor prognosis in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy.

Authors:  Y C Zeng; R Wu; Y P Xiao; F Chi; M Xue; Z Y Zhang; R Xing; W Z Zhong; S L Wang; X Tian; W Chen; J J Chen; L N Wu
Journal:  Curr Oncol       Date:  2015-02       Impact factor: 3.677

Review 5.  Inflammation and cancer: how friendly is the relationship for cancer patients?

Authors:  Bharat B Aggarwal; Prashasnika Gehlot
Journal:  Curr Opin Pharmacol       Date:  2009-08-06       Impact factor: 5.547

6.  Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer.

Authors:  Kotaro Hirashima; Masayuki Watanabe; Hironobu Shigaki; Yu Imamura; Satoshi Ida; Masaaki Iwatsuki; Takatsugu Ishimoto; Shiro Iwagami; Yoshifumi Baba; Hideo Baba
Journal:  J Gastroenterol       Date:  2013-07-03       Impact factor: 7.527

7.  The predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancer.

Authors:  G Kasymjanova; N MacDonald; J S Agulnik; V Cohen; C Pepe; H Kreisman; R Sharma; D Small
Journal:  Curr Oncol       Date:  2010-08       Impact factor: 3.677

8.  The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study.

Authors:  M J Proctor; D Talwar; S M Balmar; D S J O'Reilly; A K Foulis; P G Horgan; D S Morrison; D C McMillan
Journal:  Br J Cancer       Date:  2010-08-17       Impact factor: 7.640

Review 9.  Management of non-small-cell lung cancer: recent developments.

Authors:  Martin Reck; David F Heigener; Tony Mok; Jean-Charles Soria; Klaus F Rabe
Journal:  Lancet       Date:  2013-08-24       Impact factor: 79.321

Review 10.  Does the immune system naturally protect against cancer?

Authors:  Alexandre Corthay
Journal:  Front Immunol       Date:  2014-05-12       Impact factor: 7.561
View more
  1 in total

1.  C-Reactive Protein and C-Reactive Protein-Based Scores to Predict Survival in Esophageal and Junctional Adenocarcinoma: Systematic Review and Meta-Analysis.

Authors:  Cliona M Lorton; Larissa Higgins; Niamh O'Donoghue; Claire Donohoe; Jim O'Connell; David Mockler; John V Reynolds; Declan Walsh; Joanne Lysaght
Journal:  Ann Surg Oncol       Date:  2021-11-12       Impact factor: 5.344
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.